SCHEMBL4610586

SCHEMBL4610586

CN(C)C(=O)C1(N2CCCC2=O)CCN(Cc2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
CYP2D6 P10635 4/20 0.46
ALDH1A1 P00352 1/20 0.45
CHRM2 P08172 2/20 0.43
CHRM3 P20309 1/20 0.43
SIGMAR1 Q99720 3/20 0.42
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42
OPRL1 P41146 2/20 0.42
CYP3A4 P08684 2/20 0.41
POLB P06746 1/20 0.41
DRD2 P14416 1/20 0.41
HTR2A P28223 1/20 0.41
HTR2C P28335 1/20 0.41
HTR2B P41595 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4610609 0.82 CYP3A4 (0.55) TSHRCYP2D6ALDH1A1CYP3A4POLB
SCHEMBL4942336 0.81 TSHR (0.70) TSHRCYP2D6ALDH1A1CHRM2CHRM3
SCHEMBL6158787 0.79 CYP3A4 (0.54) TSHRCYP2D6ALDH1A1CYP3A4POLB
SCHEMBL6162538 0.78 MEN1 (0.47) ALDH1A1HTR2CHSD17B10OPRD1OPRK1
SCHEMBL14434387 0.76 TSHR (0.56) TSHRCYP2D6ALDH1A1SIGMAR1OPRM1
SCHEMBL6159676 0.75 L3MBTL1 (0.51) TSHRCYP2D6ALDH1A1SIGMAR1GRIN2D
SCHEMBL3905409 0.74 LMNA (0.51) TSHRCYP2D6ALDH1A1SIGMAR1OPRL1
SCHEMBL4611388 0.73 BRD4 (0.33) ALDH1A1BRD4
SCHEMBL3896141 0.71 SIGMAR1 (0.50) TSHRCYP2D6ALDH1A1CHRM2CHRM3
SCHEMBL9377754 0.71 DRD2 (0.51) TSHRCYP2D6ALDH1A1CHRM2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1979319-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS Solvay Pharmaceuticals GmbH (DE) 2008-10-15 EP disclosed
WO-2007088181-A1 NOVEL DUAL NK2/NK3-ANTAGONISTS, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESSES FOR THEIR PREPARATIONS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-08-09 WO disclosed